Close Menu

NEW YORK (GenomeWeb) – Bionano Genomics on Wednesday lowered the size of its proposed IPO, according to a filing with the US Securities and Exchange Commission.

The San Diego-based genomic research tools company plans to offer 2,450,000 units, each consisting of one share of common stock and one warrant to purchase a share of common stock, at a price of $6.00 to $7.00 per unit.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.